Offered an antidepressant in perimenopause: is $598 worth it?

Over two years, your weight has climbed, your sleep has come apart and your mood has gone flat in a way you do not recognize. You are in your late forties. You described all three changes to your doctor in one appointment and left with the offer of an antidepressant. Nobody ordered further tests or made a plan for the weight. Nobody explained why you now wake before dawn.

If you were offered an antidepressant in perimenopause and are now looking at a membership that begins with $598, the money is a fair objection. You have already paid for one visit that ended in one prescription. You are right to ask whether another $598 buys anything different. This piece answers that question plainly. It explains what the $598 covers, when it becomes a charge, what it pays for in your first two months and who should keep the money in the bank.

GoodLife Health offers clinician-led hormone care with insulin, thyroid and lipids read together, by video and message in all fifty states, for $299 a month. It tests first and treats second. It takes nothing on any medication it prescribes. Whether that is worth $598 to you depends on what your last visit left undone.

Two years of change and one prescription on offer

The changes probably did not arrive on the same day. Perhaps the weight came first, a few pounds each season that no longer came off with the habits that used to work. Then the nights changed. You fell asleep easily enough and woke at 3 AM with your mind already running. Then came the mornings when your patience was gone before lunch. None of it felt like an illness on its own. Taken together over two years, it feels like living in a different body.

You did the reasonable thing. You booked an appointment and listed the weight, the sleep and the mood. Insurance-based primary care runs on short visits. Our guide to the real ROI of a $299 membership puts them at eight to 18 minutes. In that time a doctor hears three complaints and has room to act on perhaps one. A prescription for mood fits inside a single visit. A workup for weight and sleep does not, which may be why the antidepressant was the whole offer.

Perhaps you also heard the sentence: “Your labs are normal.” Perhaps you heard that this is stress or simply age. Neither is a diagnosis. Both tend to end the conversation.

An antidepressant may be the right medicine for you. Nothing in this piece argues otherwise. The difficulty is the order of events. A prescription arrived before anyone had looked at the weight, the sleep and the mood as parts of one picture. If you take the medicine, you still do not know why the other two changed. If you decline it, you leave with nothing at all.

That history is why $598 feels heavy. The number is the smaller part of the objection. The larger part is the fear of paying again for the same answer. You have already spent time, a copay and some trust on a visit that left two of your three questions where it found them. Before you spend more, you want to know what the money buys that the last visit did not. That is the right test to apply to us. The rest of this piece is written to pass it or to tell you plainly where it does not.

What a short visit sees and what it leaves out

A standard panel compares each of your numbers with a reference range. The range describes a population. It tells you whether a value is unusual among many people. It cannot tell you whether that value has moved for you over two years, because a single draw shows a point and not a direction. Normal is a population range. You are not a population.

Medicine is moving toward a different order of work. The direction is testing before treating and then following the same markers over time. Fasting insulin now sits beside glucose and is measured before glucose turns abnormal. ApoB is read where LDL was once the only lipid number anyone discussed. Membership care with a clinician who stays is replacing the eight-minute visit that has to choose one complaint out of three. None of this is speculative. It is the work a labs-first clinic does every quarter.

In GoodLife Health's hormone care, three groups of markers are read beside your symptoms:

• Fasting Insulin and Hemoglobin A1c (HbA1c), read together.
• Thyroid function, through TSH With Reflex To Free T4, every quarter.
• Apolipoprotein B (ApoB) and Lipid Panel, Standard, which move after menopause.

None of these tests is exotic. What changes the result is drawing them together, reading them against how you have felt and drawing them again 90 days later to see what moved. A clinician who has your two-year history and a first panel in front of them is answering a different question from the one your last visit answered.

The conversation about hormone therapy has changed as well. Its labeling was revised in February 2026. If hormone therapy came up before then and was waved away as risky, that answer rested on the older label. It deserves a new conversation with a clinician who reads your numbers. At GoodLife Health, that decision is made case by case.

We do not know what lies behind your two years. Neither does any article. A clinician may read your first panel and find your markers where they should be. That result has value too, because it narrows the question. If an antidepressant is offered again after that reading, it comes with the whole picture in view. You can decide about it with far more information than you had in the short visit.

You could also take this list back to your own doctor and ask for the tests. That is a sensible step and costs you one more visit. Some doctors will order them. Some will tell you insurance will not cover them. Even when the tests are drawn, the short visit still has to fit the reading, the explanation and the plan into the same few minutes, with the next look often a year away.

What the first $598 covers and what it does not

The $598 is held on your card at sign-up and covers your first two months. It is a hold, not a charge. It becomes a charge only once a clinician reviews your intake and accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. From the third month, the membership is $299 a month, month to month.

The path runs in a fixed order. You take the eligibility check, complete the intake and go through checkout. A clinician then reviews your case and decides whether this model fits you. Not everyone is accepted. If you are not, applying has cost you some time and nothing else.

For $299 a month, the membership covers the following:

• Clinicians licensed in all fifty states, with one clinician who stays with you.
• Four cardiometabolic lab panels a year, one each quarter.
• Every result in your hands.
• Messaging with the care team between visits.
• Video visits.

The fee is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge.

In your first two months, the fee pays for an intake that takes the whole two years into account, a first panel drawn before any prescription and a clinician who reads the results with you. That first panel is where clinician-led hormone care with insulin, thyroid and lipids read together begins. If treatment is indicated, it starts from those results. If it is not, you will know why. Across the year, the fee pays for something a single appointment cannot produce, which is a line of markers followed over time and read by the same clinician each time.

Medication sits outside the fee. When a clinician judges a medication indicated, it is prescribed to the pharmacy you choose at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on it. Only branded, FDA-approved medication is prescribed. Our guide to bioidentical hormone therapy at pharmacy cost shows what hormone prescriptions commonly run when no one in the chain takes a margin. If a weight medication is ever indicated, the manufacturers publish their own self-pay prices. As of September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills and $349 a month after. The $199 price is an introductory offer for new patients through December 2026. LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose. A pharmacy that bills you follows its own return and refund policy.

The membership does not replace your insurance. It pairs with insurance for catastrophic coverage, so keep your plan for the hospital and for anything outside the scope of this care. GoodLife Health is precision direct primary care for cardiometabolic health. It replaces the short visit for the questions you have been carrying. It does not cover everything a general practice does. It does not promise hormone therapy, weight loss or any prescription. It offers no in-office procedures, which means no hormone pellets. It is not urgent care.

A year of membership is $3,588. That is a real sum. It is worth setting against what else you might buy. Our ROI guide prices the alternatives as published in September 2026. Mid-tier concierge retainers run $1,500 to $5,000 a year. The visits are still billed to insurance, so the year costs the retainer plus your insurance. The $20,000-a-year concierge practice sits well above that range. Insurance-based primary care carries no membership fee, though it is not free. The Kaiser Family Foundation's 2025 employer survey found an average employee premium contribution of $1,440 a year and an average deductible of $1,886. You keep paying those with or without us. What changes is what the $3,588 buys on top of them.

At the other end of the market is the $99-a-month compounded app. We do not compete with its price. The difference that matters to you is who earns what when a prescription is written. GoodLife Health sells neither the drug nor the dose. An antidepressant, a hormone, a weight medication or nothing at all earns us the same $299. Nothing in the model rewards a prescription written before the labs are read.

The case for starting now comes from your own calendar. Two years of change have passed without a workup. A first panel this month gives you a baseline. The next one, 90 days later, shows whether anything has moved. If hormone therapy was set aside before February 2026, the new labeling is a reason to reopen the question with someone who reads your markers. Another season of waiting leaves the price where it is and adds three months to the history.

What to do this week, whether or not you join

Some of this needs no membership. You can start it this week.

• Ask your doctor's office for a copy of every result from the past two years. Keep them in one place.
• Write the timeline down. Note when the weight began to change, when the sleep broke and when the mood turned.
• Ask which markers were drawn. Ask directly whether fasting insulin, thyroid and ApoB were among them.
• If hormone therapy was ruled out, ask when that was. Then ask whether the February 2026 relabeling changes the answer.
• Do not start, stop or change a medication because of anything you read here. Talk first to the clinician who prescribed it.

If your mood has reached the point of crisis, do not wait for a membership or a panel. Contact your doctor or emergency services today.

With your results and your timeline in hand, any clinician, ours or another, can begin further along than your last visit did. That is worth doing whatever you decide about the $598.

Who this is not for

If your doctor is already ordering a fuller panel and following up on it, stay where you are. You may not need us. If you want a guaranteed prescription, a promise of hormone therapy or a set amount of weight lost, we cannot offer any of those and will not pretend to. If you want hormone pellets or another in-office procedure, this is the wrong place. If $598 at the start would strain your household this month, wait until it would not. The two years behind you make a workup worth doing. They do not make it worth putting ahead of your other obligations. If what you want is the lowest monthly price for a prescription, a $99 app will suit you better. We would rather say so now than after you have joined.

GoodLife Health is $299 a month. The first two months, $598, are held on your card at sign-up and charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, those two months are non-refundable. From the third month, the membership is month to month. The fee buys a quarterly panel, every result in your hands and a clinician who stays. Medication is prescribed to your pharmacy at that pharmacy's price, with nothing taken on it. Its billing follows that pharmacy's own return and refund policy. What comes back is the diagnosis a short visit never produced, your markers followed over time and an end to the eight-minute visit. The difference is the order of work. GoodLife Health tests first, treats second and sells neither the drug nor the dose. If two years have passed without anyone reading your insulin, thyroid and lipids together, the next 90 days are a sensible place to start.

Related Reading

• Bioidentical Hormone Therapy at Pharmacy Cost: The Real Numbers
• The Real ROI of a $299/Month Health Membership: Every Alternative, Priced Honestly

References

1. 2025 Employer Health Benefits Survey — Kaiser Family Foundation. 2025. www.kff.org/health-costs/2025-employer-health-benefits-survey/
2. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
3. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings